The Medicines Company to Present at J. P. Morgan Healthcare Conference

04 Jan 2017

The Medicines Company (Nasdaq: MDCO) today announced that its Chief Executive Officer, Clive Meanwell, M.D., Ph.D., will present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017, at 7:30 a.m., Pacific time.

A live audio webcast of the presentation will be available in the “Investors” section of The Medicines Company website,, under “Events/Presentations.” A replay of the presentation will be available.

About The Medicines Company

The Medicines Company is a biopharmaceutical company driven by an overriding purpose — to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in three critical therapeutic areas: serious infectious disease care, cardiovascular care and surgery and perioperative care. The Company is headquartered in Parsippany, New Jersey, with global innovation centers in California and Switzerland.


The Medicines Company
Meg Langan, (973) 290-6319
Vice President
Investor Relations
Krishna Gorti, MD, (973) 290-6122
Vice President, Investor Relations

Contact Us

The Medicines Company
8 Sylvan Way
Parsippany, NJ 07054 USA
Tel 973 290 6000
Toll-free 800 388 1183
Global Medical Information